BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21970370)

  • 1. Activating mutation in MET oncogene in familial colorectal cancer.
    Neklason DW; Done MW; Sargent NR; Schwartz AG; Anton-Culver H; Griffin CA; Ahnen DJ; Schildkraut JM; Tomlinson GE; Strong LC; Miller AR; Stopfer JE; Burt RW
    BMC Cancer; 2011 Oct; 11():424. PubMed ID: 21970370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
    Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
    Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
    Zhang YZ; Sheng JQ; Li SR; Wu ZT
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients.
    Jiang L; Huang J; Morehouse C; Zhu W; Korolevich S; Sui D; Ge X; Lehmann K; Liu Z; Kiefer C; Czapiga M; Su X; Brohawn P; Gu Y; Higgs BW; Yao Y
    Cancer Genet; 2013; 206(9-10):330-9. PubMed ID: 24200637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
    Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN
    Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
    Schmidt LS; Nickerson ML; Angeloni D; Glenn GM; Walther MM; Albert PS; Warren MB; Choyke PL; Torres-Cabala CA; Merino MJ; Brunet J; Bérez V; Borràs J; Sesia G; Middelton L; Phillips JL; Stolle C; Zbar B; Pautler SE; Linehan WM
    J Urol; 2004 Oct; 172(4 Pt 1):1256-61. PubMed ID: 15371818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.
    Neklason DW; Kerber RA; Nilson DB; Anton-Culver H; Schwartz AG; Griffin CA; Lowery JT; Schildkraut JM; Evans JP; Tomlinson GE; Strong LC; Miller AR; Stopfer JE; Finkelstein DM; Nadkarni PM; Kasten CH; Mineau GP; Burt RW
    Cancer Res; 2008 Nov; 68(21):8993-7. PubMed ID: 18974144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease.
    Woods MO; Younghusband HB; Parfrey PS; Gallinger S; McLaughlin J; Dicks E; Stuckless S; Pollett A; Bapat B; Mrkonjic M; de la Chapelle A; Clendenning M; Thibodeau SN; Simms M; Dohey A; Williams P; Robb D; Searle C; Green JS; Green RC
    Gut; 2010 Oct; 59(10):1369-77. PubMed ID: 20682701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
    Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
    Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.
    Bellido F; Sowada N; Mur P; Lázaro C; Pons T; Valdés-Mas R; Pineda M; Aiza G; Iglesias S; Soto JL; Urioste M; Caldés T; Balbín M; Blay P; Rueda D; Durán M; Valencia A; Moreno V; Brunet J; Blanco I; Navarro M; Calin GA; Borck G; Puente XS; Capellá G; Valle L
    Gastroenterology; 2018 Jan; 154(1):181-194.e20. PubMed ID: 28912018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.
    Tode N; Kikuchi T; Sakakibara T; Hirano T; Inoue A; Ohkouchi S; Tamada T; Okazaki T; Koarai A; Sugiura H; Niihori T; Aoki Y; Nakayama K; Matsumoto K; Matsubara Y; Yamamoto M; Watanabe A; Nukiwa T; Ichinose M
    Cancer Sci; 2017 Jun; 108(6):1263-1270. PubMed ID: 28294470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
    da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
    J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer risks in relatives of young-onset cases: is risk the same across all first-degree relatives?
    Boardman LA; Morlan BW; Rabe KG; Petersen GM; Lindor NM; Nigon SK; Goldberg J; Gallinger S
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1195-8. PubMed ID: 17702662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial risks for colorectal cancer show evidence on recessive inheritance.
    Hemminki K; Chen B
    Int J Cancer; 2005 Jul; 115(5):835-8. PubMed ID: 15704173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer.
    Fields JZ; Gao Z; Gao Z; Lewis M; Maimonis P; Harvey J; Lynch HT; Boman BM
    J Lab Clin Med; 2004 Jan; 143(1):59-66. PubMed ID: 14749686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.